🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of selvigaltin wh...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2026-04-01
Trial ID
NCT07082270
Treatments Being Tested
This study will assess the relative bioavailability, safety and tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02504320
This study is designed to assess prototype formulations compared to the aqu...
Status
Completed
Location
AMREP Centre for Clinical Studies
Start Date
2012-04
Trial ID
NCT01383096
This randomized, double-blind, placebo-controlled, two-period crossover stu...
Status
Completed
Location
University of Bari
Start Date
2024-05-01
Trial ID
NCT07724067
Treatments Being Tested
Primary objectives are to demonstrate bioequivalence between 4 and 8 mg of ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-10
Trial ID
NCT00807118
Treatments Being Tested
A Phase 2 trial to confirm the dose and formulation, demonstrate adjuvant e...
Status
Terminated
Location
US135
Start Date
2018-09-24
Trial ID
NCT03658629
Treatments Being Tested
This is a single-centre, 2-part, randomised, single-dose parallel group stu...
Status
Completed
Location
Quotient Clinical
Start Date
2015-04
Trial ID
NCT02387580
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of: sin...
Status
Terminated
Location
New Zealand Clinical Research
Start Date
2022-07-04
Trial ID
NCT05423106
This study will evaluate the safety and efficacy of bimatoprost 0.03% formu...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-01
Trial ID
NCT01099774
Treatments Being Tested
This phase II trial compares the combination of selinexor, daratumumab and ...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-07-23
Trial ID
NCT06169215